BioCatalystWatch
ALZNWorkspace / ALZN / OverviewCompany library
Alzamend Neuro, Inc. logo

Alzamend Neuro, Inc.

Alzamend Neuro, Inc. (ALZN)

Website

Price
Market cap
Next catalystFinal healthy-subject study results expected December 2026AL001 — healthy-adult imaging study · Phase 2 dataSEC filing ↗
Cash

Chart & Events

Candle interval

Core Clinical

AL001

PreINDP1P2P3FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

AL001

PreINDP1P2P3FilingApproved
Upcoming / outlook

Other pipelines

AL001

PreINDP1P2P3FilingApproved
AL001

AL001

History / paused

AL001

PreINDP1P2P3FilingApproved

Financial position

Short-term investments

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

ALZN PR & News

PR & News

ALZN SEC archive